18
8
2
41
1500
2
4
90
10
14
29
Total | Fijo | Interino | Eventual | |
---|---|---|---|---|
Número de residentes formados en los últimos 3 años con un puesto laboral fijo | 14 | 9 | 4 | 1 |
Contratados a los 6 meses de terminar la residencia | 2 | 0 | 2 | 0 |
Contratados al año de terminar la residencia | 2 | 0 | 2 | 0 |
Contratados a los 2 años de terminar la residencia | 2 | 2 | 0 | 0 |
Contratados a los 3 años de terminar la residencia | 4 | 3 | 1 | 0 |
Contratados a los 4 años de terminar la residencia | 6 | 4 | 1 | 1 |
Tipo de patología | Periodicidad | ¿Son multidisciplinares? |
---|---|---|
Artritis indiferenciadas de inicio (semanal) | ||
Artritis reumatoide de inicio (semanal) | ||
Artritis psoriásica y espondiloartropatías ( 2 sesiones a la semana) | ||
Clínica de transición (semanal) | ||
Osteoporosis inducida por glucocorticoides (semanal) | ||
Artritis inducida por imunoterapia (semanal) | ||
Artritis reumatoide refractaria (semanal) |
Periodicidad | |
---|---|
Sesión Bibliográfica del Servicio de Reumatología | |
Sesión Bibliográfica para Residentes del Servicio de Reumatología | |
Sesión Clinica del Servicio de Reumatología | |
Sesión de Medicina Interna | |
Sesión General del Hospital Clínic para Residentes | |
Sesiones de la Societat Catalana de Reumatología | |
Comité de Enfermedad pulmonar intersticial (semanal) | |
Comité de Uveítis (mensual) |
Docente | Categoría | Grado | Acreditación Aneca | Acreditación Autonómica |
---|---|---|---|---|
Dra. Nuria Guañabens Gay | Catedrático | Licenciatura en Medicina | Sí Titular y Catedrático | Sí AQU Investigación e Investigación Avanzada |
Dr. Raimon Sanmartí Sala | Asociado | Licenciatura en Medicina | No | No |
Dra. Pilar Peris Bernal | Asociado | Licenciatura en Medicina | No | No |
Dr. Jose A Gómez Puerta | Asociado | Licenciatura en Medicina | No | No |
Título | Autores | Revista | Año | Impact F | Cuartiles |
---|---|---|---|---|---|
Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis. | Castellanos-Moreira R, Rodriguez-Garcia SC, Cabrera-Villalba S, Gomara MJ, Salvador G, Ruiz-Esquide V, Ramirez J, Inciarte-Mundo J, Morlà R, Garcia-Moreno C, Cuervo A, Gómez-Puerta JA, Cañete JD, Haro I, | Ther Adv Musculoskelet Dis. | 2020 | 5.043 | |
Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors. | Londoño MC, Reig M; RETOINMUNO Multidisciplinary Group. | Cancers (Basel) | 2020 | 6.126 | |
Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis. | Urrego-Callejas T, Álvarez SS, Arias LF, Reyes BO, Vanegas-García AL, González LA, Muñoz-Vahos CH, Vásquez G, Quintana LF, Gómez-Puerta JA. | Clin Rheumatol | 2020 | 2.394 | |
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses. | Florez H, Hernández-Rodríguez J, Carrasco JL, Prieto-González S, Muxi A, Filella X, Ruiz-Gaspà S, Gómez-Puerta JA, Cid M, Espinosa G, Monegal A, Guañabens N, Peris P. | RMD Open | 2020 | -- | |
A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. | Frade-Sosa B, Narváez J, Salman-Monte TC, Castellanos-Moreira R, Ortiz-Santamaria V, Torrente-Segarra V, Castellví I, Magallares B, Reina D, Minguez S, Sallés M, Manrique de Lara MG, Ordoñez S, Riera E, Schur PH, Gómez-Puerta JA. | Lupus | 2020 | 2.251 | |
Coexistence of antiphospholipid syndrome and cryoglobulinemia in a patient with rheumatoid arthritis. | Cajiao K, Gómez-Puerta JA. | Clin Rheumatol | 2020 | 2.394 | |
Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. | Castellanos-Moreira R, Rodríguez-García SC, Gomara MJ, Ruiz-Esquide V, Cuervo A, Casafont-Solé I, Ramírez J, Holgado S, Gómez-Puerta JA, Cañete JD, Haro I, Sanmarti R. | Ann Rheum Dis | 2020 | 16.102 | |
Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. | Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC, Espinosa G, Gómez-Puerta JA, Monegal A, Guañabens N, Peris P | Rheumatology (Oxford) | 2020 | 5.606 | |
Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype? | Castellanos-Moreira R, Rodriguez-Garcia SC, Gómez-Puerta JA, Ruiz-Esquide V, Camacho O, Ramírez J, Cuervo A, Morlà R, Cañete JD, Haro I, Sanmarti R. | J Rheumatol | 2020 | 3.350 | |
Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis. | Julià A, Ávila G, Celis R, Sanmartí R, Ramírez J, Marsal S, Cañete JD. | Arthritis Res Ther | 2020 | 4.103 | |
Is Auto-Antibody Expansion the Turning Point Between Idiopathic Pulmonary Fibrosis and Rheumatoid Arthritis? | Castellanos-Moreira R, Rodriguez-Garcia SC, Hernandez-Gonzalez F, Sellares J, Haro I, Sanmarti R. | Chest | 2020 | 8.308 | |
Relationship between rheumatoid arthritis and interstitial lung disease is a 'two-way street'. Response to: 'Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a 'mix-and-match' approach' by Alunno et al. | Castellanos-Moreira R, Rodríguez-García SC, Haro I, Sanmarti R. | Ann Rheum Dis | 2020 | 16.102 | |
Ultrasound findings in palindromic rheumatism. | Sanmarti R, Ramírez J, Castellanos-Moreira R, Cabrera-Villalba SR, Ruiz-Esquide V, Salvador G. | Ann Rheum Dis | 2020 | 16.102 | |
Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review. | Calvo Alén J, Pérez T, Romero Yuste S, Ferraz-Amaro I, Alegre Sancho JJ, Pinto Tasende JA, Maceiras Pan F, Quevedo JC, Hernández-Hernández MV, Hidalgo Calleja C, San Martín Álvarez A, Sánchez MIT, Sanmartí R | Reumatol Clin | 2020 | -- | |
Assessing treatment tolerability for rheumatoid arthritis. Validation and practical applications of the 'TOL-AR-18 questionnaire'. | Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R. | Reumatol Clin | 2020 | -- | |
Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review. | Sanmartí R, Tornero J, Narváez J, Muñoz A, Garmendia E, Ortiz AM, Abad MA, Moya P, Mateo ML, Reina D, Salvatierra-Ossorio J, Rodriguez S, Palmou-Fontana N, Ruibal-Escribano A, Calvo-Alén | Reumatol Clin | 2020 | -- | |
Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study. | Queiro R, Cañete JD, Montoro M, Gómez S, Cábez A; MAAPS study group | Arthritis Res Ther | 2020 | 4.103 | |
The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review. | Cañete JD, Tasende JAP, Laserna FJR, Castro SG, Queiro R | Rheumatol Ther | 2020 | 3.615 | |
Good clinimetric alignment between remission and a low impact of disease in patients with axial psoriatic arthritis. | Queiro R, Cañete JD. | Clin Exp Rheumatol | 2020 | 3.319 | |
Biological Treatment Patterns in Patients with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up. | Cañete JD, Naranjo A, Calvo J, Ordás C, Aragón B, Nocea G, Roset M, Fernández-R Nebro A. | Reumatol Clin | 2020 | -- | |
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients. | Fernández-Díaz C, Castañeda S, Melero-González RB, Ortiz-Sanjuán F, Juan-Mas A, Carrasco-Cubero C, Casafont-Solé I, Olivé A, Rodríguez-Muguruza S, Almodóvar-González R, Castellanos-Moreira R, Rodríguez-García SC, Aguilera-Cros et al | Rheumatology (Oxford) | 2020 | 5.606 | |
Imaging Follow-up of SAPHO Syndrome Treated With Zoledronic Acid. | Rodriguez-García SC, Castellanos-Moreira R, Muxí A, Del Amo M, Peris P, Guañabens N. | J Clin Rheumatol | 2020 | 2.360 | |
Sternal Stress Fractures: An Unusual Cause of Chest Pain in Patients With Osteoporosis. | Cajiao K, Florez H, Peris P. | J Clin Rheumatol | 2020 | 2.360 | |
Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis. | Ruiz-Gaspà S, Guañabens N, Jurado S, Combalia A, Peris P, Monegal A, Parés A. | Liver Int | 2020 | 5.175 | |
Multifocal Osteonecrosis: The Usefulness of Bone Scintigraphy. | Cajiao K, Setoain FJ, Peris P. | J Clin Rheumatol | 2020 | 2.360 | |
Effect of antiresorptive and bone forming treatments in bone erosions in rheumatoid arthritis. | Azuaga-Piñango AB, Peris P | Med Clin (Barc) | 2020 | 1.635 | |
Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases. | Ruiz-Gaspà S, Guañabens N, Jurado S, Dubreuil M, Combalia A, Peris P, Monegal A, Parés A | Gene | 2020 | 2.984 | |
Fusion of sacroiliac joints in acromegaly: a challenging finding. | Frade-Sosa B, Florez H, Isern-Kebschull J, Halperin I, Guañabens N | Rheumatology (Oxford) | 2020 | 5.606 | |
Effectiveness of ustekinumab in patients with psoriatic arthritis in a real-world, multicenter study. | Azuaga AB, Frade-Sosa B, Laiz A, Estrada P, Prior-Español A, Horcada L, Polino L, Moreno M, Moragues C, Urruticoechea-Arana A, Sellas A, Tandaipan JL, Torrente-Segarra V, Garcia-Miguel J, Ros I, Ordoñez S, Moya P, Reina D, Mateo-Soria L, Fito C, Beltrán E, Pujol M, Cuervo AM, Cañete JD, Ramírez J; ESPOCAT group. | Clin Rheumatol | 2020 | 2.394 | |
Colchicine as a possible therapeutic option in COVID-19 infection. | Parra-Medina R, Sarmiento-Monroy JC, Rojas-Villarraga A, Garavito E, Montealegre-Gómez G, Gómez-López A. | Clin Rheumatol | 2020 | 2.394 | |
Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in ClinicalRemission: A Randomized, Open-Label Trial | Sanmarti R, Veale DJ, Martin-Mola E, Escudero-Contreras A, González C, Ercole L, Alonso R, Fonseca JE | Arthritis Rheumatol | 2019 | 9.586 | |
Definition of Remission and Disease Activity Assessment in Psoriatic Arthritis: Evidence and Expert-Based Recommendations. | Almodóvar R, Cañete JD, de Miguel E, Pinto JA, Queiro R. | Reumatol Clin | 2019 | -- | |
Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype? | Castellanos-Moreira R, Rodriguez-Garcia SC, Gómez-Puerta JA, Ruiz-Esquide V, Camacho O, Ramírez J, Cuervo A, Morlá R, Cañete JD, Haro I, Sanmarti R. | J Rheumatol | 2019 | 3.350 | |
Psoriatic Synovitis: Singularity and Potential Clinical Implications. | Celis R, Cuervo A, Ramírez J, Cañete JD | Front Med (Lausanne) | 2019 | 3.900 | |
MAAPSStudy Group. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis. | Queiro R, Cañete JD, Montilla C, Abad MA, Montoro M, Gómez S, Cábez A | J Rheumatol | 2019 | 3.350 | |
Biological Treatment Patterns in Patients with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up. | Cañete JD, Naranjo A, Calvo J, Ordás C, Aragón B, Nocea G, Roset M, Fernández-Nebro A. | Reumatol Clin. | 2019 | -- | |
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. | Aterido A, Cañete JD, Tornero J et al. | Ann Rheum Dis. | 2019 | 16.102 | |
Grupo de Trabajo del Proyecto REAPSER. Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology. | Queiro R, Laiz A, Seoane-Mato D, Galindez Agirregoikoa E, Montilla C, Park HS, Bethencourt Baute JJ, Bustabad S, Pinto Tasende JA, Tejón P, Joven Ibáñez B, Ramírez J, Cuervo A, Cañete JD | Reumatol Clin | 2019 | -- | |
Exposure-response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components. | Bastida C, Soy D, Ruiz-Esquide V, Sanmartí R, Huitema ADR. | Br J Clin Pharmacol | 2019 | 3.740 | |
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis. | Gratacós J, Pontes C, Juanola X, Sanz J, Torres F, Avendaño C, Vallano A, Calvo G, de Miguel E, Sanmartí R; REDES-TNF investigators | Arthritis Res Ther. | 2019 | 4.103 | |
Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. | Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC, Espinosa G, Gómez-Puerta JA, Monegal A, Guañabens N, Peris P | Rheumatology (Oxford) | 2019 | 5.606 | |
Fusion of sacroiliac joints in acromegaly: a challenging finding. | Frade-Sosa B, Florez H, Isern-Kebschull J, Halperin I, Guañabens N | Rheumatology (Oxford) | 2019 | 5.606 | |
Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone. | Guañabens N, Filella X, Florez H, Ruiz-Gaspá S, Conesa A, Peris P, Monegal A, Torres F. | Bone | 2019 | 4.147 | |
The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment. | Guañabens N, Moro-Álvarez MJ, Casado E, Blanch-Rubió J, Gómez-Alonso C, Díaz- Guerra GM, Del Pino-Montes J, Valero Díaz de Lamadrid C, Peris P, Muñoz-Torres M; SEIOMM Working Group. | Endocrine | 2019 | 3.235 | |
Imaging Follow-up of SAPHO Syndrome Treated With Zoledronic Acid. | Rodríguez-García SC, Castellanos-Moreira R, Muxí A, Del Amo M, Peris P, Guañabens N. | J Clin Rheumatol | 2019 | 2.360 | |
Spontaneous vertebral fractures after denosumab discontinuation: A case collection and review of the literature. | Florez H, Ramírez J, Monegal A, Guañabens N, Peris P. | Semin Arthritis Rheum | 2019 | 4.751 | |
Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study. | Kanterewicz E, Puigoriol E, Rodríguez Cros JR, Peris P. | Osteoporos Int | 2019 | 3.864 | |
HMGB1 + microparticles present in urine are hallmarks of nephritis in patients with systemic lupus erythematosus. | Burbano C, Gómez-Puerta JA, Muñoz-Vahos C, Vanegas-García A et al. | Eur J Immunol. | 2019 | 4.404 | |
Fibromyalgia. Old opinions versus new knowledge. | Collado A, Rivera J, Alegre C, Casanueva B. | Reumatol Clin | 2020 | -- | |
Characterization of Burnout Among Spanish Family Physicians Treating Fibromyalgia Patients: The EPIFFAC Study. | Torres X, Ojeda B, Collado A, Solé E, Vergara J, Gómez E, Castells X, Arias A.J | J Am Board Fam Med | 2020 | 2.661 | |
Antinuclear antibodies mitotic patterns and their clinical associations. | Betancur JF, Gómez-Puerta JA. | Ann Rheum Dis | 2019 | 16.102 | |
An overrepresentation of elderly subjects in a population-based study of Antiphospholipid Syndrome. | Gómez-Puerta JA, Cervera R, Alarcón GS | Arthritis Rheumatol | 2019 | 9.586 | |
Tocilizumab in the treatment of adult rheumatoid arthritis. Immunotherapy | Sanmartí R, Ruiz-Esquide V, Bastida C, Soy D | Immunotherapy | 2018 | 3.46 | |
Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study | Balsa A, Sanmartí R, Rosas J, Martin V, Cabez A, Gómez S, Montoro M. | Rheumatology (Oxford) | 2018 | 5.24 | |
Dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis | Bastida C, Ruiz-Esquide V, Pascal M, de Vries Schultink AHM, Yagüe J, Sanmartí R, Huitema ADR, Soy D | Br J Clin Pharmacol | 2018 | 3.83 | |
Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review. | Calvo Alén J, Pérez T, Romero Yuste S, Ferraz-Amaro I, Alegre Sancho JJ, Pinto Tasende JA, Maceiras Pan F, Quevedo JC, Hernández-Hernández MV, Hidalgo Calleja C, San Martín Álvarez A, Sánchez MIT, Sanmartí R. | Reumatol Clin | 2018 | 0.53 | |
Anakinra for the treatment of rheumatoid arthritis: a safety evaluation | Ramírez J, Cañete JD | Expert Opin Drug Saf | 2018 | 3.15 | |
Sustained response to Rituximab in a TNFi-induced ANCA-vasculitis developed in a patient with rheumatoid arthritis | Florez H, Morlà R, Castellanos-Moreira R, Sanmartí R | Semin Arthritis Rheum | 2018 | 3.94 | |
Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association? | Queiro R, Cañete JD | Clin Rheumatol | 2018 | 2.14 | |
Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis | Urrego T, Ortiz-Reyes B, Vanegas-García AL, Muñoz CH, González LA, Vásquez G, Gómez-Puerta JA | Reumatol Clin | 2018 | 0.53 | |
Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients | Gómez-Puerta JA, Ortiz-Reyes B, Urrego T, Vanegas-García AL, Muñoz CH, González LA, Cervera R, Vásquez G | Lupus | 2018 | 2.96 | |
Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review | Maese J, Díaz Del Campo P, Seoane-Mato D, Guerra M, Cañete JD | Reumatol Clin | 2018 | 0.53 | |
Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA | Gifre L, Humbert L, Muxi A, Del Rio L, Vidal J, Portell E, Monegal A, Guañabens N, Peris P | Osteoporosis Int | 2018 | 3.85 | |
Osteoporosis in chronic liver disease | Guañabens N, Parés A | Liver Int | 2018 | 4.11 | |
Identification of hypophosphatasia in a clinical setting: Clinical manifestations and diagnostic recommendations in adult patients | Guañabens N, Blanch J, Martínez-Díaz-Guerra G, Muñoz Torres M. | Med Clin (Barc) | 2018 | 1.16 | |
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the 'TOL-AR-18 Questionnaire | Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R. | Reumatol Clin | 2018 | 0.53 | |
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis. | Tornero Molina J, Balsa Criado A, Blanco García F, Blanco Alonso R, Bustabad S, Calvo Alen J, Corominas H, Fernández Nebro A, Román Ivorra JA, Sanmartí R. | Reumatol Clin | 2018 | 0.53 | |
Efficacy and Safety of Glucocorticoids in Rheumatoid Arthritis: Systematic Literature Review. | Sanmartí R, Tornero J, Narváez J, Muñoz A, Garmendia E, Ortiz AM, Abad MA, Moya P, Mateo ML, Reina D, Salvatierra-Ossorio J, Rodriguez S, Palmou-Fontana N, Ruibal-Escribano A, Calvo-Alén J | Reumatol Clin | 2018 | 0.53 | |
Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations | Betancur JF, Londoño A, Estrada VE, Puerta SL, Osorno SM, Loaiza A, Carmona JA, Gómez-Puerta JA. | Medicine (Baltimore) | 2018 | 2.028 | |
Variability in Rheumatology day care hospitals in Spain: VALORA study | Hernández Miguel MV, Martín Martínez MA, Corominas H, Sanchez-Piedra C, Sanmartí R, Fernández Martínez C, García-Vicuña R; en representación del Comité Científico del proyecto VALORA | Reumatol Clin | 2017 | 0.53 | |
Anti C1q antibodies. A promising biomarker for cocaine-levamisole induced vasculitis. | Gómez-Puerta JA, Muñoz CH, Vanegas-García AL, Urrego T, Vásquez G, González LA | Reumatol Clin | 2017 | 0.53 | |
Recommendations for the use of methotrexate in psoriatic arthritis | Cañete JD, Ariza-Ariza R, Bustabad S, Delgado C, Fernández-Carballido C, García Llorente JF, Loza E, Montilla C, Naranjo A, Pinto JA, Queiro R, Ramírez J, Tornero-Molina J | Reumatol Clin | 2017 | 0.53 | |
Safety profile of biological therapies for treating rheumatoid arthritis. | Cañete JD, Hernández MV, Sanmartí R | Expert Opin Biol Ther | 2017 | 3.15 | |
Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis | Cabrera-Villalba S, Gomara MJ, Cañete JD, Ramírez J, Salvador G, Ruiz-Esquide, V, Hernández MV, Inciarte-Mundo J, Haro I, Sanmartí R | Arthritis Res Ther | 2017 | 4.12 | |
Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up | Ramírez J, Narváez JA, Ruiz-Esquide V, Hernández-Gañán J, Cuervo A, Inciarte-Mundo J, Hernández MV, Sampayo-Cordero M, Pablos JL, Sanmartí R, Cañete JD | Semin Arthritis Rheum | 2017 | 3.94 | |
Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study | Queiro R, Cañete JD, Montilla C, Abad M, Montoro M, Gómez S, Cábez A; MAAPS study group | Arthritis Res Ther | 2017 | 4.12 | |
Concordance between direct and indirect measurements of free 25-OH vitamin D. | Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat study group | Clin Chim Acta | 2017 | 2.92 | |
Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study | Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat Study Group | Osteoporos Int | 2017 | 3.85 | |
Is anti-inflammatory radiotherapy an effective treatment in trochanteritis? | Valduvieco I, Biete A, Moreno LA, Gallart X, Rovirosa A, Saez J, Plana C, Peris P | Br J Radiol | 2017 | 2.05 | |
Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy. | Gifre L, Ruiz-Gaspà S, Carrasco JL, Portell E, Vidal J, Muxi A, Monegal A, Guañabens N, Peris P | Osteoporos Int | 2017 | 3.85 | |
Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis | Ramírez J, Nieto-González JC, Curbelo Rodríguez R, Castañeda S, Carmona L | Semin Arthritis Rheum | 2017 | 3.94 | |
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts | García-Doval I, Hernández MV, Vanaclocha F, Sellas A, de la Cueva P, Montero D; BIOBADADERM and BIOBADASER study groups | Br J Dermatol | 2017 | 6.12 | |
Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission. | Ramírez J, Iniciarte-Mundo J, Cuervo A, Ruiz-Esquide V, Hernández MV, Sanmartí R, Cañete JD. | Clin Exp Rheumatol | 2017 | 2.72 | |
Calprotectin andTNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoidarthritis and psoriatic arthritis patients in remission or with low disease activity | Inciarte-Mundo J, Ramírez J, Hernández MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, Pascal M, Yagüe J, Cañete JD, Sanmartí R | Arthritis Res Ther | 2016 | 4.12 | |
Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission | Ramírez J, Celis R, Usategui A, Ruiz-Esquide V, Faré R, Cuervo A, Sanmartí R, Pablos JL, Cañete JD | Arthritis Res Ther | 2016 | 4.12 | |
Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review. | Candelas G, Villaverde V, García S, Guerra M, León MJ, Cañete JD | Rheumatol Int | 2016 | 1.95 | |
Reliability and Accuracy of MRI Laminar Angle Measurements to Determine Intra-Procedural Contralateral Oblique View Angle for Cervical or Thoracic Interlaminar Epidural Steroid Injections | Levi DS, Horn S, Collado A | Pain Med | 2016 | 2.78 | |
The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries | Collado A, Torres X, Messina OD, Vidal LF, Clark P, Ríos C, Solé E, Arias A, Perrot S, Salomon PA | Pain Med | 2016 | 2.78 | |
Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment | Monegal A, Peris P, Alsina M, Colmenero J, Guañabens N. | Osteoporos Int | 2016 | 3.85 | |
Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis | Guañabens N, Ruiz-Gaspà S, Gifre L, Miquel R, Peris P, Monegal A, Dubrueil M, Arias A, Parés A | J Bone Miner Res | 2016 | 6.31 |
Título | Autores | Revista | Año | Impact F | Cuartiles |
---|---|---|---|---|---|
Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison. | Izcovich A, Alarcón GS, Gómez-Puerta JA, Pons-Estel GJ, Ugarte-Gil MF, Cardiel MH, Pons-Estel BA; GLADEL study group. | Rheumatology (Oxford) | 2020 | 5.606 | |
Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis. | Andreev D, Liu M, Kachler K, Llerins Perez M, Kirchner P, Kölle J, Gießl A, Rauber S, Song R, Aust O, Grüneboom A, Kleyer A, Cañete JD, Ekici A, Ramming A, Finotto S, Schett G, Bozec A | Ann Rheum Dis | 2020 | 16.102 | |
Delayed soft tissue emphysema of the leg following arthroscopy of the knee. | Tomas X, Atilano L, Cañete JD, Pomes J, Del Amo M, Macias N. | Med Clin (Barc) | 2020 | 1.635 | |
IL6/sIL6R regulates TNFa-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanisms. | Valin A, Del Rey MJ, Municio C, Usategui A, Romero M, Fernández-Felipe J, Cañete JD, Blanco FJ, Ruano Y, Criado G, Pablos JL. | BMC Mol Cell Biol. | 2020 | -- | |
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study. | Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Cañete JD, Perrotta FM. | Rheumatol Ther | 2020 | 3.615 | |
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. | Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, Primdahl J, McGonagle DG, Aletaha D, Balanescu A, Balint PV, Bertheussen H, Boehncke WH, Burmester GR, Canete JD | Ann Rheum Dis | 2020 | 16.102 | |
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. | Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, Steffen F, Omata Y, Rings A, Bertog M, Rizzo A, Iljazovic A, Basic M, Kleyer A, Culemann S, Krönke G, Luo Y, Überla K, Gaipl US, Frey B, Strowig T, Sarter K, Bischoff SC, Wirtz S, Cañete JD, Ciccia F, Schett G, Zaiss MM. | Nat Commun. | 2020 | 12.121 | |
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices. | Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Cañete JD, Perrotta FM. | RMD Open | 2020 | -- | |
Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countries. | Palominos PE, Coates L, Kohem CL, Orbai AM, Smolen J, de Wit M, Kiltz U, Leung YY, Cañete JD, Scrivo R | Joint Bone Spine | 3.741 | ||
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure. | Blanco FJ, Rubio-Romero E, Sanmartí R, Díaz-Torné C, Talavera P, Dunkel J, Naredo E; SONAR Study Team. | Reumatol Clin | 2020 | -- | |
Practical Aspects of Biological Throught Levels and Antidrug Antibodies in Rheumatoid Arthritis and Spondyloarthritis. | Rosas J, Martín-López M, Otón T, Balsa A, Calvo-Alén J, Sanmartí R, Tornero J, Carmona L. | Reumatol Clin | 2020 | -- | |
Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations. | Bastida C, Huitema ADR, l'Ami MJ, Ruiz-Esquide V, Wolbink GJ, Sanmartí R, Soy D. | Eur J Clin Pharmacol | 2020 | 2.641 | |
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis | Tornero-Molina J, Alperi-López M, Castellví I, de Agustín-de Oro JJ, Escudero A, García-Vicuña R, González-Gay MÁ, Hidalgo C, Rubio E, Sanmartí R, Casamira N, Calvo-Alén J | Reumatol Clin | 2020 | -- | |
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study. | Fernández-Carballido C, Martín-Martínez MA, García-Gómez C, Castañeda S, González-Juanatey C, Sánchez-Alonso F, García de Vicuña R, Erausquin-Arruabarrena C, López-Longo J, Sánchez MD, Corrales A, Quesada-Masachs E, Chamizo E, Barbadillo C, Bachiller-Corral J, Cobo-Ibañez T, Turrión A, Giner E, Llorca J, González-Gay MA; Cardiovascular in Rheumatology Project Collaborative Group | Arthritis Care Res (Hoboken) | 2020 | 4.056 | |
Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study. | Cañete JD, Nolla JM, Queiro R, Rodríguez MJ, Ruiz M, Lizán L; MERECES Working Group. | J Rheumatol | 2020 | 3.350 | |
Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis. | Combe B, Rahman P, Kameda H, Cañete JD, Gallo G, Agada N, Xu W, Genovese M | Arthritis Res Ther | 2020 | 4.103 | |
B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure. | Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A, Hands RE, Giorli G, Frias B, Thorborn G, Jaworska E, John C, Goldmann K, Lewis MJ, Manzo A, Bombardieri M, Pitzalis C; PEAC-R4RA Investigators | Arthritis Rheumatol | 2020 | 9.586 | |
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. | Ruiz de Morales JMG, Puig L, Daudén E, Cañete JD, Pablos JL, Martín AO, Juanatey CG, Adán A, Montalbán X, Borruel N, Ortí G, Holgado-Martín E, García-Vidal C, Vizcaya-Morales C, Martín-Vázquez V, González-Gay MÁ | Autoimmun Rev. | 2020 | 7.767 | |
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries. | Orbai AM, Perin J, Gorlier C, Coates LC, Kiltz U, Leung YY, Palominos PE, Cañete JD, Scrivo R et al. | Arthritis Care Res (Hoboken) | 2020 | 4.056 | |
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort. | Cronin O, Subedi D, Forsyth L, Goodman K, Lewis SC, Keerie C, Walker A, Porteous M, Cetnarskyj R, Ranganath LR, Selby PL, Hampson G, Chandra R, Ho S, Tobias JH, Young-Min SA, McKenna MJ, Crowley RK, Fraser WD, Tang J, Gennari L, Nuti R, Brandi ML, Del Pino-Montes J, Devogelaer JP, Durnez A, Isaia GC, Di Stefano M, Rubio JB, Guanabens N, Seibel MJ et al | J Bone Miner Res. | 2020 | 5.854 | |
Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. | Bianchi ML, Bishop NJ, Guañabens N, Hofmann C, Jakob F, Roux C, Zillikens MC; Rare Bone Disease Action Group of the European Calcified Tissue Society | Osteoporos Int. | 2020 | 3.864 | |
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society. | van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Guañabens N, Eastell R, Ralston SH, Zillikens MC. | J Clin Endocrinol Metab. | 2020 | 5.399 | |
Response to: Some Questions About the Article 'The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report'. | Buchbinder R, Ebeling PR, Akesson K, Bauer DC, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, et al | J Bone Miner Res. | 2020 | 5.854 | |
Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. | Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B | J Clin Endocrinol Metab | 2020 | 5.399 | |
Quality standard for the management of patients with psoriatic arthritis: QUANTUM Project. | Sanz Sanz J, Beltrán E, Díaz-Miguel Pérez MC, Fernández-Carballido C, Galíndez E, García Porrua C, Gratacós J, Medina J, Queiro R, Ramírez J, Reina D, Rodríguez Lozano C, Rodríguez Martínez FJ, Rubio E, Veroz R. | Reumatol Clinc | 2020 | -- | |
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort | Quintana R, Pons-Estel GJ, Roberts K, Sacnún M, Serrano R, Nieto R, Conti S, Gervasoni V, Catoggio LJ, Soriano ER, Scolnik M, García MA, Alvarellos A, Saurit V, Berbotto GA, Sato EI, Costallat LTL, Neto EFB, Bonfa E, Xavier RM, de Oliveira E Silva Montandon AC, Molina-Restrepo JF, Iglesias-Gamarra A, Guibert-Toledano M, Reyes-Llerena GA, Massardo L, Neira OJ, Cardiel MH, Barile-Fabris LA, Amigo MC, Silveira LH, Torre IG, Acevedo-Vásquez EM, Ugarte-Gil MF, Alfaro-Lozano JL, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Gomez-Puerta JA, Alarcón GS, Pons-Estel BA. | Lupus | 2020 | 2.251 | |
Pneumococcal superinfection in COVID-19 patients: A series of 5 cases. | Cucchiari D, Pericàs JM, Riera J, Gumucio R, Md EC, Nicolás D; Hospital Clínic 4H Team. | Med Clin (Barc) | 2020 | 1.635 | |
Clinical Characteristics and Renal Prognosis Associated with Interstitial Fibrosis and Tubular Atrophy (IFTA) and Vascular Injury in Lupus Nephritis Biopsies. | Leatherwood C, Speyer CB, Feldman C, D´Silva K, Gómez-Puerta JA, Hoover PJ, Waikar SS, McMahon M, Rennke H, Costenbader KH | Semin Arthritis Rheum | 2019 | 4.751 | |
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a multi-ethnic, multinational Latin-American Lupus Cohort. | Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Quintana R, Gómez-Puerta JA, Catoggio LJ, et al. | J Rheumatol | 2019 | 3.350 | |
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure | Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A, Hands RE, Giorli G, Frias B, Thorborn G, Jaworska E, John C, Goldmann K, Lewis MJ, Manzo A, Bombardieri M, Pitzalis C; PEAC- R4RA investigators. | Arthritis Rheumatol | 2019 | 9.586 | |
Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype. | Del Rey MJ, Valín Á, Usategui A, Ergueta S, Martín E, Municio C, Cañete JD, Blanco FJ, Criado G, Pablos JL. | Immun Ageing | 2019 | 2.804 | |
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association with Gender in 458 Patients from 14 Countries. | Orbai AM, Perin J, Gorlier C, Coates LC, Kiltz U, Leung YY, Palominos PE, Cañete JD, Scrivo R, Balanescu A, Dernis E, Tälli S, Ruyssen-Witrand A, Soubrier M, Aydin S, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, Smolen JS, de Wit M, Gossec L | Arthritis Care Res (Hoboken) | 2019 | 4.056 | |
Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis. | Rodríguez-Ubreva J, de la Calle-Fabregat C, Li T, Ciudad L, Ballestar ML, Català-Moll F, Morante-Palacios O, Garcia-Gomez A, Celis R, Humby F, Nerviani A, Martin J, Pitzalis C, Cañete JD, Ballestar E | Ann Rheum Dis. | 2019 | 16.102 | |
A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis. | Aterido A, Cañete JD, Tornero J, Blanco F, Fernández-Gutierrez B, Pérez C, Alperi-López M, Olivè A, Corominas H, Martínez-Taboada V, González I, Fernández- Nebro A, Memoria del Erra A, López-Lasanta M, López Corbeto M, Palau N, Marsal S, Julià A | Front Immunol | 2019 | 5.085 | |
Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis | Hannemann N, Cao S, Eriksson D, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, Rech J, Ramming A, Uebe S, Ekici A, Cañete JD, et al. | J Clin Invest | 2019 | 11.864 | |
A potential SNP association with response to etanercept. | Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete JD et al. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. | PLoS One | 2019 | 2.740 | |
Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content. | Chen S, Noordenbos T, Blijdorp I, van Mens L, Ambarus CA, Vogels E, Te Velde A, Alsina M, Cañete JD, Yeremenko N, Baeten D. | Rheumatology (Oxford). | 2019 | 5.606 | |
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries. | Gorlier C, Orbai AM, Puyraimond-Zemmour D, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD et al. | Ann Rheum Dis. | 2019 | 16.102 | |
Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation. | de Agustín JJ, Erra A, Ponce A, Moragues C, Díaz-Torné C, Reina D, Moreno E, Ramírez J, Mateo L, Pujol Busquets M, Moya P, Santo-Panero P, Ros-Expósito S, Narváez J, Sanmartí R, García de Yébenes MJ, Carmona L. | Rheumatol Int | 2019 | 1.984 | |
Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis. | García-Moreno C, Gómara MJ, Bleda MJ, Sanmartí R, Haro I. | PLoS One. | 2019 | 2.740 | |
Impact of Comorbidity on Physical Function in Patients with Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics. Results from the CARdiovascular in rheumatology (CARMA) study. | Fernández-Carballido C, Martín-Martínez MA, García-Gómez C, Castañeda S, González-Juanatey C, Sánchez-Alonso F, de Vicuña RG, Erausquin-Arruabarrena C, López-Longo J, Sánchez MD, Corrales A, Quesada-Masachs E, Chamizo E, Barbadillo C, Bachiller-Corral J, Cobo-Ibañez T, Turrión A, Giner E, Llorca J, González-Gay MA | Arthritis Care Res (Hoboken). | 2019 | 4.056 | |
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study. | Moreno M, Gratacós J, Torrente-Segarra V, Sanmarti R, Morlà R, Pontes C, Llop M, Juanola X; REMINEA study Group. | Arthritis Res Ther | 2019 | 4.103 | |
CARMA Project Collaborative Group. Hyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project. | García-Gómez C, Martín-Martínez MA, Fernández-Carballido C, Castañeda S, González-Juanatey C, Sanchez-Alonso F, González-Fernández MJ, Sanmartí R, et al. | Clin Exp Rheumatol | 2019 | 3.319 | |
Effects of concomitant glucocorticoids in TOZURA, a common-framework Memoria del Servicio de Reumatología, study programme of subcutaneous tocilizumab in rheumatoid arthritis. | Choy E, Caporali R, Xavier R, Fautrel B, Sanmarti R, Bao M, Devenport J, Pethö-Schramm A. | Rheumatology (Oxford). | 2019 | 5.606 | |
Medical management of patients after atypical femur fractures: a systematic review and recommendations from ECTS. | van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Guañabens N, Eastell R, Ralston SH, Zillikens MC | J Clin Endocrinol Metab. | 2019 | 5.399 | |
Balancing benefits and risks in the era of biologics. | Adami G, Saag KG, Chapurlat RD, Guañabens N et al. | Ther Adv Musculoskelet Dis | 2019 | 5.043 | |
Clinical Guidelines on Paget's Disease of Bone. | Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, Guañabens N et al | J Bone Miner Res. | 2019 | 2.297 | |
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent mediated Paget's disease of bone. | Cronin O, Forsyth L, Goodman K, Lewis SC, Keerie C, Walker A, Porteous M, Cetnarskyj R, Ranganath LR, Selby PL, Hampson G, Chandra R, Ho S, Tobias JH, Young-Min S, McKenna MJ, Crowley RK, Fraser WD, Gennari L, Nuti R, Brandi ML, Del Pino-Montes J, Devogelaer JP, Durnez A, Isaia G, Di Stefano M, Guañabens N, Et al | BMJ Open | 2019 | 2.496 | |
Response Letter to the Editor-Diamond et al | Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML. | J Bone Miner Res | 2019 | 2.297 | |
Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline | Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, Guañabens N et al | J Bone Miner Res | 2019 | 2.297 | |
Prevalence of fibromyalgia among women with deep infiltrating endometriosis. | Coloma JL, Martínez-Zamora MA, Collado A, Gràcia M, Rius M, Quintas L, Carmona F | Int J Gynaecol | 2019 | 2.216 | |
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries. | Choy E, Caporali R, Xavier R, Fautrel B, Sanmartí R, Bao M, Bernasconi C, Pethö-Schramm A | Rehumatology (Oxford) | 2018 | 5.24 | |
The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab. | Diaz-Torne C, Ortiz MDA, Moya P, Hernandez MV, Reina D, Castellvi I, De Agustin JJ, Fuente D, Corominas H, Sanmartí R, Zamora C, Cantó E, Vidal S. | Semin Arthritis Rheum. | 2018 | 3.94 | |
Recommendations for the use of parenteral methotrexate in rheumatic diseases. | Tornero Molina J, Calvo Alen J, Ballina J, Belmonte MÁ, Blanco FJ, Caracuel MÁ, Carbonell J, Corominas H, Chamizo E, Hidalgo C, Ivorra JR, Marenco JL, Moreno Muelas JV, Muñoz-Fernández S, Nolla JM, Pérez T, Sanmartí R, Trenor P, Urrego C, Vidal J, Rosas G | Reumatol Clin | 2018 | 0.53 | |
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review. | Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R. | Clin Exp Rheumatol | 2017 | 2.72 | |
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project. | Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, Dreyer L, Hetland ML, Cordtz R, Hyrich K, Strangfeld A, Zink A, Canhao H, Hernandez MV, Tubach F, Gottenberg JE, Morel J, Zavada J, Iannone F, Askling J, Listing J. | Ann Rheum Dis | 2017 | 12.35 | |
Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach? | Acebes C, Andreu JL, Balsa A, Batlle E, de Toro-Santos J, García Llorente F, Hernández MV, Fernández-Gutiérrez B, Hidalgo-Calleja C, Mayordomo L, Naredo E, Narváez FJ, Ortiz AM, Pablos JL, Pérez-Sandoval T, Rodríguez-Lozano C, Sánchez-Pernaute O, Usón J, | Clin Exp Rheumatol | 2017 | 2.72 | |
González C, Curbelo Rodríguez R, Torre-Alonso JC, Collantes E, Castañeda S, Hernández MV, Urruticoechea-Arana A, Nieto-González JC, García J, Abad MÁ, Ramírez J, Suárez C, Dalmau R, Martín-Arranz MD, León L, Hermosa JC, Obaya JC, Otón T, Carmona L | González C, Curbelo Rodríguez R, Torre-Alonso JC, Collantes E, Castañeda S, Hernández MV, Urruticoechea-Arana A, Nieto-González JC, García J, Abad MÁ, Ramírez J, Suárez C, Dalmau R, Martín-Arranz MD, León L, Hermosa JC, Obaya JC, Otón T, Carmona L | Reumatol Clin | 2017 | 0.53 | |
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the | Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Choquette D, Finckh A | Clin Rheumatol | 2017 | 2.14 | |
Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. | Martínez López JA, García Vivar ML, Cáliz R, Freire M, Galindo M, Hernández MV, López Longo FJ, Martínez Taboada V, Pego Reigosa JM, Rubio E, Trujillo E, Vela-Casasempere P | Reumatol Clin | 2017 | 0.53 | |
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis | Torre Alonso JC, Díaz Del Campo Fontecha P, Almodóvar R, Cañete JD, Montilla Morales C, Moreno M, Plasencia-Rodríguez C, Ramírez García J, Queiro R. | Reumatol Clin | 2017 | 0.53 | |
Genetic variation associated with cardiovascular risk in autoimmune diseases | Perrotti PP, Aterido A, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Domènech E, Fernández-Gutiérrez B, Gomollón F, García-Planella E, Fernández E, Sanmartí R, Gratacós J, Martínez-Taboada VM, Rodríguez-Rodríguez L, Palau N, Tortos | Plos One | 2017 | 2.80 | |
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells | Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Lin NY, Dietel K, Bozec A, Herrmann M, Kaplan MH, Weigmann B, Zaiss MM, Fearon U, Veale DJ, Cañete JD, Distler O, Rivellese F, Pitzalis C, Neurath MF, McKenzie ANJ, Wirtz S, Schett G, Distler JH | Nat Med | 2017 | 29.88 | |
Synovial tissue research: a state-of-the-art review | Orr C, Vieira-Sousa E, Boyle DL, Buch MH, Buckley CD, Cañete JD, Catrina AI, Choy EHS, Emery P, Fearon U, Filer A, Gerlag D, Humby F, Isaacs JD, Just SA, Lauwerys BR, Le Goff B, Manzo A, McGarry T, McInnes IB, Najm A, Pitzalis C, Pratt A, Smith M, Tak | Nat Rev Rheumatol | 2017 | 12.18 | |
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts | Fernández-Gutiérrez B, Perrotti PP, Gisbert JP, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, García-Sánchez V, Panés J, Fonseca E, Blanco F, Rodríguez-Moreno J, Carreira P, Julià A, Marsal S, Rodríguez-Rodríguez L; IMID Consortium | Medicine (Baltimore) | 2017 | 2.02 | |
Hif-1a Knockdown Reduces Glycolytic Metabolism and Induces Cell Death of Human Synovial Fibroblasts Under Normoxic Conditions. | Del Rey MJ, Valín Á, Usategui A, García-Herrero CM, Sánchez-Aragó M, Cuezva JM, Galindo M, Bravo B, Cañete JD, Blanco FJ, Criado G, Pablos JL | Sci Rep | 2017 | 4.12 | |
Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study. | Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, Heiberg T, Helliwell PS, Kalyoncu U, Kvien TK, Kiltz U, Niedermayer D, Otsa K, Scrivo R, Smolen J, Stamm TA, Veale DJ, de Vlam K, de Wit M, Gossec L | Arthritis Care Res | 2017 | 4.71 | |
The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation | Levels MJ, Van Tok MN, Cantaert T, Cañete JD, Kroese FG, Germar K, Spits H, Baeten DL, Yeremenko NG | Arthritis Rheumatol | 2017 | 7.87 | |
Uncommon local reaction at the injection site of subcutaneous methotrexate. | Fustà X, Combalia A, Guañabens N, Iranzo P. | Rheumatology (Oxford) | 2017 | 5.24 | |
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. | Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC. | Bone | 2017 | 4.45 | |
Pain, Quality of Life, and Safety Outcomes of Kyphoplasty for Vertebral Compression Fractures: Report of a Task Force of the American Society for Bone and Mineral Research. | Rodríguez AJ, Fink HA, Mirigian L, Guañabens N, Eastell R, Akesson K, Bauer DC, Ebeling PR | J Bone Miner Res | 2017 | 6.31 |
Título | Autores | Revista | Año | Impact F | Cuartiles |
---|---|---|---|---|---|
Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia | Florez H, Mandelikova S, Filella X, Monegal A, Guañabens N, Peris P | Med Clin (Barc) | 2017 | 1.16 |
Título del capítulo | Autor | Título del libro | ISBN | Año de publicación |
---|---|---|---|---|
Management of nonrenal and non-central nervous system lupus | Gómez-Puerta JA, Espinosa G, Cervera R | Rheumatology Hochberg | 978-0-70206865-2 | 2019 |
Artiritis Reumatoide | Sanmartí R, Ruiz-Esquide V, Inciarte-Mundo J | Reumatología, Fundamentos de Medicina | 9,78959E+12 | 2018 |
Artritis Psoriásica | Ramírez J, Cañete JD | Reumatología, Fundamentos de Medicina | 9,78959E+12 | 2018 |
Tratamiento del Lupus eritematoso sistémico | González LA, Molina JF, Gómez Puerta JA. | Reumatología, Fundamentos de Medicina | 9,78959E+12 | 2018 |
Artropatías enteropáticas | Gómez-Puerta JA | Reumatología, Fundamentos de Medicina | 9,78959E+12 | 2018 |
Sindrome Antifosfolipídico | Gómez-Puerta JA | Reumatología, Fundamentos de Medicina | 9,78959E+12 | 2018 |
Terapia Biológica no Anti TNF | Hernández MV | Reumatología, Fundamentos de Medicina | 9,78959E+12 | 2018 |
Enthesitis | Cañete JD, Ramírez J | Oxford Textbook of Psoriatic Arthritis | 9,7802E+12 | 2018 |
Osteomalacia | Peris P | Tratado de Enfermedades Reumáticas de la Sociedad Española de Reumatología | 9,78849E+12 | 2018 |
Artritis Psoriásica | Cañete JD | Tratado de Enfermedades Reumáticas de la Sociedad Española de Reumatología | 9,78849E+12 | 2018 |
Biología Articular | Cuervo A | Tratado de Enfermedades Reumáticas de la Sociedad Española de Reumatología | 9,78849E+12 | 2018 |
Osteoporosis II | Guañabens N | Tratado de Enfermedades Reumáticas de la Sociedad Española de Reumatología | 9,78849E+12 | 2018 |
Management of nonrenal and non-central nervous system lupus | Gómez-Puerta JA, Espinosa G, Cervera R | Rheumatology Hochberg | 9,7807E+12 | 2018 |
Artritis Reumatoide | Sanmartí R | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
Inmunopatología de la Artritis Reumatoide | Ramírez J, Cañete JD | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
Artritis reumatoide de inicio reciente | Ruiz-Esquide V, Cabrera S, Sanmartí R | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
Evolución y pronóstico de la artritis reumatoide | Sanmartí R, Camacho O | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
Tratamiento de la artritis reumatoide | Hernández MV | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
Amiloidosis | Cuervo A, Muñoz Gómez J | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
Enfermedad Mixta de tejido Conectivo | Gómez-Puerta JA | Enfermedades Inflamatorias reumatológicas | 9,78995E+12 | 2016 |
The Spectrum of Rheumatic Diseases | Calle E, Gómez-Puerta JA | Surgery in Rheumatic and Musculoskeletal Disease | 9,78044E+12 | 2016 |
Título del proyecto | Año | Competitivo | Propio/colaboración |
---|---|---|---|
GLADEL 2.0 Biomarcadores en paciente con Lupus Eritematoso Sistémico (PANLAR) | 2020 | No | Colaboración |
Estudio de la Epidemiología de la osteoporosis en población Española. En el que se analizará la prevalencia de osteoporosis en la población, los parámetros de arquitectura ósea y la composición corporal y posteriormente, la incidencia de fracturas y sus determinantes | 2019 | No | Colaboración |
Registro de la osteomalacia hipofosfatémica ligada al cromosoma X (XLH) y en el estudio sobre la carga de la enfermedad | 2019 | No | Colaboración |
Financiación: Kyowa Kirin International | |||
Registro de la osteomalacia hipofosfatémica ligada al cromosoma X (XLH) y en el estudio sobre la carga de la enfermedad | 2019 | No | Colaboración |
Financiación: Kyowa Kirin International | |||
3TR: Taxonomy, Treatment, Targets and Remission: Identification of the Molecular Mechanisms of nonresponse to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | 2019 | Sí | Colaboración |
CarMa Evaluación del riesgo cardiovascular, y de sus determinantes, en pacientes con artritis reumatoide, espondilitis anquilosante y artritis psoriásica. | 2019 | No | Colaboración |
CM-Fibromics project: Identification of new targets, pathways and biomarkers, in co and multimorbidities combining mental and pain disorders on fibromyalgia, based on an omics analysis and clinical features | 2019 | No | Colaboración |
“Eficacia Y Seguridad Del Bloqueo Inter-Fascial En El Tratamiento Del Dolor En El Trapecio De Pacientes Con Fibromialgia: Estudio Piloto, Enmascarado A Ciego Simple Y Controlado Con Placebo” Protocolo:Eco-Intermiofascial-4444 | 2019 | Sí | Propio |
Biomarcadores sinoviales y séricos de mal pronóstico en Artritis Indiferenciadas de inicio. Un estudio longitudinal, prospectivo, de 18 meses de seguimiento | 2018 | Sí | Propio |
Reguladors del remodelatge ossi i mètodes avançats d’imatge (TBS i VFA) per la valoració del risc de fractura en pacients tractats amb glucocorticoids | 2017 | Sí | Propio |
RD16/0012/0010. Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER). | 2016 | Sí | Colaboración |
Risks and benefitis of moderate beer intake (with and without alcohol) on osteoporosis in postmenopausal women: A 2-year randomized clinical trial | 2016 | Sí | Colaboración |
Título del ensayo | Año | Industria farmacéutica |
---|---|---|
ARIAA | 2021 | No |
IM101-477 | ||
University Hospital Erlangen | ||
JADY 14060 I4V-MC-JADY E | 2021 | Sí |
(Eli Lilly) | ||
PALABA | 2021 | Sí |
IM101-680 (BMS) | ||
COMBO | 2021 | Sí |
M16-063 (AbbVie) | ||
C-View | 2020 | Sí |
AS0007 (UCB) | ||
COMPACT | 2020 | Sí |
GP15-501 (SANDOZ) | ||
VORSO | 2020 | No |
VC2018-2 | ||
203168 (GSK) | 2019 | Sí |
Avert2 | 2019 | Sí |
IM101-550 (BMS) | ||
STRAP-EU | 2018 | No |
R4-RA | 2018 | No |
Estudio BEAM. (Lilly) | 2018 | Sí |
NCT01232569. To SPACE (Roche) | 2017 | Sí |
FRI0158. Optibio study | 2017 | No |
FIS AR-ZOL | 2017 | No |
Estudio ZIPP- Paget | 2017 | No |
CAIN457F2318. Future 2 | 2016 | Sí |
CAIN457H2315 (Novartis) | 2016 | Sí |
CAIN457F2342 (Novartis) | 2016 | Sí |
CAIN457F2366 (Novartis) | 2016 | Sí |